Welcome to Global Integrated Reimbursement Services, Inc. (GIRS)
Your PATH to Medical Technology Reimbursement
Every day, brilliant minds are hard at work on the world’s next medical technology breakthrough. However, even the greatest healthcare innovation will have limited success without patient access and affordability. Global Integrated Reimbursement Services, Inc. (GIRS) has over 13 years of reimbursement consulting expertise helping clients navigate the complex reimbursement landscape to improve market uptake of pharmaceuticals, biologics, diagnostics, medical devices, combination products, biosimilars and surgical supplies. We assist our clients to develop reimbursement strategies that are integrated with clinical outcomes strategies, marketing strategies and regulatory strategies.
MUCH MORE THAN CODING
GIRS is a Reimbursement Consulting Company Offering Support Services and Reimbursement Strategies for Biologics, Medical Devices, Combination Products, Surgical Supplies, Pharmaceuticals, and Medical Diagnostics
To successfully launch your medical product, you’ve got to crack the code. Our certified coders and reimbursement consultants develop short – term and long – term coding strategies. In addition, we have a near – perfect record for successful coding applications and coding verifications. More…
Payer coverage policies greatly impact patient access. Our Payer Advocacy Compass (PAC) team has developed key industry relationships required to be effective payer advocates in your quest for medical policy coverage for drugs, medical devices, biologics, diagnostics, and combination products. More…
The GIRS InContact Reimbursement Line staff provides expert and safe support to your accounts for coding, coverage, and billing questions and assist with appeals and benefit verifications. Our reimbursement hotlines improve patient access to breakthrough medical devices, drugs, surgical supplies, and diagnostics. More…
For market uptake and to remain competitive, pharmaceutical, medical devices, biologics, and diagnostics manufacturers must be able to demonstrate payer – desired clinical and economic evidence to insurers, and other stakeholders. More…
The Imperium division of GIRS develops and implements leading solutions in healthcare management, contact center support, website marketing and upgrades, training and outreach to support our government clients in meeting their goals. More…
The bridge between you and payers.
Since 2003, our dedicated team of experts have nurtured industry relationships necessary to deliver successful integrated reimbursement strategies for pharmaceuticals, biologics, diagnostics, medical devices, combination products, biosimilars, and surgical supplies.
WHY PARTNER WITH GIRS?
U.S. & Global Market Access Knowledge
We not only know the coverage requirements of all major U.S. payers, but we also understand market access requirements for medical technology reimbursement in Europe, Canada, the Far East, and Australia.
For over 13 years, GIRS has developed successful reimbursement strategies for a wide range of medical technologies in the U.S. and internationally.
We meticulously align reimbursement strategies with clinical, regulatory, and marketing strategies to optimize outcomes. This facilitates the successful market uptake of and patient access to breakthrough pharmaceuticals, medical devices, biologics and other types of medical technologies.
CMS Releases Medicare Physician Fee Schedule for Calendar Year 2017. See What is New for Your Accounts… On November 2, 2016, the Centers for Medicare and Medicaid Services (CMS) released the final Medicare Physician Fee Schedule (MPFS) for 2017. The Final Rule updates payment policies and payment rates for services furnished by physicians and other practitioners in all sites of service under the MPFS. These services include but are not limited to visits, surgical procedures, diagnostic tests, therapy services, and specified preventive services. These policy changes and payment rates are effective as of January 1, 2017.